https://www.greenmedinfo.com/blog/breaking-fda-announces-2-deaths-pfizer-vaccine-trial-participants-serious-adverse1
Jerusalem Post reports that Pfizer vaccine trial resulted in 2 participant deaths with serious adverse events
Looks like something might not be right.
Ah who cares, warp speed ahead!
"Former Pfizer vice president and scientific director Dr. Michael Yeadon (photo, above) and German lung specialist and parliamentarian Dr. Wolfgang Wodarg have filed an urgent application with the European Medicine Agency calling for the immediate suspension of all SARS-CoV-2 vaccine studies – particularly the BioNtech/Pfizer study on BNT162b (EudraCT number 2020-002641-42)."
https://principia-scientific.com/experts-halt-cv19-vaccines-over-infertility-other-health-concerns/
Those claims can't be true.
FDA Confirms Pfizer Vaccine Safe, Effective; Approval Expected In Dayshttps://www.dailywire.com/news/fda-confirms-pfizer-vaccine-safe-effective-approval-expected-in-daysThe Food and Drug Administration (FDA) on Tuesday released a detailed analysis of the COVID-19 vaccine from Pfizer, deeming the two-shot immunization safe and effective.
The move comes two days ahead of an FDA meeting of the Vaccines and Related Biological Products Advisory Committee, a group of independent experts set to advise the agency on whether to grant the vaccine emergency use authorization (EUA).
The agency released two separate analyses, one from its own team of scientists and a second from the vaccine’s manufacturers, Pfizer Inc. and German partner BioNTech SE. They conclude that the vaccine “met the prescribed success criteria.” The vaccine, the FDA said, is “for active immunization for the prevention of COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older.”
“Safety data from approximately 38,000 participants [greater than or equal to] 16 years of age randomized 1:1 to vaccine or placebo with a median of 2 months of follow up after the second dose suggest a favorable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA,” the FDA wrote.
The FDA’s analysis finds “no specific safety concerns identified that would preclude issuance of an EUA.” The analysis found that serious reactions were rare but side effects were common, including reactions at the site of injection, headaches and fatigue.
* * * * *
See? I told ya.